Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: Potential autoantigen in Graves' ophthalmopathy

被引:216
|
作者
Bahn, RS
Dutton, CM
Natt, N
Joba, W
Spitzweg, C
Heufelder, AE
机构
[1] Mayo Clin & Mayo Fdn, Div Endocrinol, Rochester, MN 55905 USA
[2] Univ Munich, Klinikum Innenstadt, Med Klin, D-80336 Munich, Germany
来源
关键词
D O I
10.1210/jc.83.3.998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is acknowledged that the TSH receptor (TSHr) on thyroid follicular cells is the autoantigen involved in the hyperthyroidism of Graves' disease. However, whether this receptor is expressed in extrathyroidal tissues, and whether it participates directly in the pathogenesis of Graves' ophthalmopathy (GO) are unclear. We sought to detect the expression of TSHr messenger ribonucleic acid (mRNA) and protein in orbital adipose/connective tissue specimens and in human orbital preadipocyte fibroblast cultures using liquid hybridization analysis and immunohistochemical methods. We demonstrated intact and variant TSHr mRNA transcripts and TSHr-like immunoreactivity in orbital adipose/connective tissue specimens from patients with GO. In addition, TSHr-like immunoreactivity was detected in early passage GO preadipocyte fibroblast cultures that were shown to include some adipose cells. In contrast, neither TSHr mRNA nor protein was detected in normal orbital adipose/connective tissue specimens or in late passage GO orbital fibroblast cultures containing no lipid-laden adipose cells. In conclusion, we showed that TSHr is expressed in the adipose/ connective tissue of the diseased orbit in GO. In addition, TSHr is demonstrable in early passage GO preadipocyte orbital fibroblast cultures that contain a subpopulation of adipocytes. Subsequent passaging of these cells results in the loss of both TSHr expression and adipocyte-specific staining. These results suggest that both the expression of this receptor and the accumulation of adipose tissue in the orbit in GO mag be induced in vivo by a humoral factor(s) not present in the fell culture environment.
引用
收藏
页码:998 / 1002
页数:5
相关论文
共 50 条
  • [41] GRAVES OPHTHALMOPATHY AND THE TSH RECEPTOR
    FRANKLYN, JA
    LANCET, 1993, 342 (8867): : 318 - 319
  • [42] Thyroid transcription factor-1 in orbital adipose tissues: Potential role in orbital thyrotropin receptor expression
    Bhattacharyya, KK
    Coenen, MJ
    Bahn, RS
    THYROID, 2005, 15 (05) : 422 - 426
  • [43] A GENOMIC POINT MUTATION IN THE EXTRACELLULAR DOMAIN OF THE THYROTROPIN RECEPTOR IN PATIENTS WITH GRAVES OPHTHALMOPATHY
    BAHN, RS
    DUTTON, CM
    HEUFELDER, AE
    SARKAR, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (02): : 256 - 260
  • [44] The expression of interleukin-15 and interleukin-17 in tears and orbital tissues of Graves ophthalmopathy patients
    Chen, Qun
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (04) : 6299 - 6303
  • [45] Reevaluating thyrotropin receptor-induced mouse models of Graves' disease and ophthalmopathy
    Baker, G
    Mazziotti, G
    von Ruhland, C
    Ludgate, M
    ENDOCRINOLOGY, 2005, 146 (02) : 835 - 844
  • [46] IDENTIFICATION OF AN IMMUNODOMINANT REGION ON THE THYROTROPIN (TSH) RECEPTOR - THE AUTOANTIGEN IN GRAVES-DISEASE
    DALLAS, JS
    SEETHARAMAIAH, GS
    DESAI, RK
    GOLDBLUM, RM
    PRABHAKAR, BS
    FASEB JOURNAL, 1992, 6 (04): : A1445 - A1445
  • [47] Human versus mouse thyrotropin receptor as an autoantigen in a mouse model of Graves' hyperthyroidism
    Nagayama, Yuji
    ENDOCRINE JOURNAL, 2010, 57 : S237 - S237
  • [48] Comparison of the effects of orbital decompression in Graves' ophthalmopathy
    Skrzypczak, Wojciech
    Slowik, Lukasz
    Okla, Maciej
    Slebioda, Zuzanna
    Osmola, Krzysztof
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2023, 77 (01): : 154 - 162
  • [49] Increased sulfatation of orbital glycosaminoglycans in Graves' ophthalmopathy
    Hansen, C
    Rouhi, R
    Förster, G
    Kahaly, GJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04): : 1409 - 1413
  • [50] Orbital radiation therapy for Graves' ophthalmopathy - Reply
    Gorman, C
    OPHTHALMOLOGY, 2003, 110 (03) : 451 - 451